Viewing Study NCT00258895


Ignite Creation Date: 2025-12-24 @ 1:19 PM
Ignite Modification Date: 2026-01-08 @ 3:41 PM
Study NCT ID: NCT00258895
Status: COMPLETED
Last Update Posted: 2016-04-14
First Post: 2005-11-24
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Immunogenicity of DAPTACEL® as 5th Dose in Children 4 to 6 Years Old After 4 Doses of Pentacel™ or DAPTACEL®
Sponsor: Sanofi Pasteur, a Sanofi Company
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: P3T11
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators